CDMO

Navigating the Complexities of Microbial and Mammalian Manufacturing

Peter Boman; Helena Pettersson

NorthX Biologics

Recombinant Proteins

The Expanding Role for Recombinant Proteins in Research

Rob Burgess, Ph.D.

Sino Biological

Recombinant Antibodies

Taking a Customer-Focused Approach to Custom Antibody Development and Manufacturing

Rob Burgess, Ph.D.; Amy Sheng, Ph.D.; Lilith Elmore

Sino Biological

Recombinant Antibody Production

HEK Cells vs. CHO Cells in Recombinant Antibody Production: What's the Better Choice

evitria AG

Recombinant Proteins

Meeting the Renewed Demand for Microbial Protein Production

Grifols Recombinant Protein CDMO

Single-Use Technology

Facilitating Clinical Manufacturing of Recombinant Proteins with Large-Scale Single-Use Fermentation Technology

Scott Doncaster; Cameron Graham; Neil Morrison

BIOVECTRA

Recombinant Proteins

Innovation and Flexibility Drive Success During the COVID-19 Pandemic

Paul Magreta

Grifols Recombinant Protein CDMO

Virtual Panel

Leveraging a Biomanufacturing Legacy to Support New Business

Grifols Recombinant Protein CDMO

Analytical Development

Solving Process Challenges Requires Flexibility to Explore Alternative Analytical Methods

Shaonly Saha

Grifols Recombinant Protein CDMO

Plant-Based

Proprietary Protein Therapeutics with Clinically Improved Profiles

Dror Bashan

Protalix BioTherapeutics

Recombinant Proteins

New Facility Presents Manufacturing Solutions for Recombinant Proteins

Paul Magreta

Grifols Recombinant Protein CDMO

Plant-Based Solutions

Plant-based Protein Expression for Rapid, Green Bioprocessing

Robert Erwin

iBio, Inc.